N/A
Completed N=157
Managing Type 1 and High Risk Type 2 Diabetes in the Hospital Setting: Glucose as a Vital Sign
Diabetes Mellitus, Type 1 · Type 2 Diabetes Mellitus
Source: ClinicalTrials.gov NCT03068273 ↗
Enrolled (actual)
157
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcomePrimary: Type 2 Diabetes Blood Glucose Time in Range (70-180 mg/dL) — 25.31; 19.89; 26.04 percentage of time during CGM use — p=0.1460
Summary
This program will provide patients with type 1 and high risk type 2 diabetes the safest hospitalization by using wireless continuous glucose monitoring devices (CGM) to track their glucose parameters in real-time similar to other continuously monitored vital signs. The CGM will inform a team of health professionals who will monitor the patients' progress, communicate recommendations, and be available for discussion when recommended targets are not achieved. Health teams will utilize sensor results in addition to existing electronic medical records data to evaluate progress and manage care.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Type 2 Diabetes Blood Glucose Time in Range (70-180 mg/dL) |
25.31; 19.89; 26.04 | 0.1460 |
| PRIMARY Type 2 Diabetes Blood Glucose Time in Range (70-200 mg/dL) |
42.82; 33.38; 33.57 | 0.0615 |
| PRIMARY Type 2 Diabetes Blood Glucose Time in Range (70-250 mg/dL) |
72.83; 63.95; 65.97 | 0.0404 sig |
| SECONDARY Percentage Time in Hypoglycemia (<70 mg/dL) |
0; 0; 0 | 0.2680 |
| SECONDARY Percentage Time in Hyperglycemia (>250 mg/dL) |
27.00; 32.96; 34.04 | 0.0403 sig |
Eligibility Criteria
Inclusion Criteria
- Expected length of hospital stay of at least 48 hours
- One of the following:
- Diagnosed with diabetes type 1 OR
- Diagnosed with diabetes type 2, with an HbA1c > 8% or 3 point-of-care blood glucose (POC) > 200, and requiring insulin during this hospitalization.
- Literate in English or Spanish
Exclusion Criteria (not all listed):
- Pregnant or post-partum
- Patient admitted to OB unit
- Patient in ICU or with insulin drip
- Known allergy to adhesives
- Anticipated CT/MRI/diathermy procedure within 48 hours from admission (patients with a planned operation within 48 hours from admission may be included in the study post operation).
Data sourced from ClinicalTrials.gov (NCT03068273). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.